Prognostic value of different CT measurements in early therapy response evaluation in patients with metastatic colorectal cancer
| Autor: | Martin W. Huellner, Tiffany Hennedige, Burkhardt Seifert, Patrick Veit-Haibach, Klaus Strobel, R Winterhalder, Sudhakar K. Venkatesh, Thilo Zander, W P Yong, T C Treumann, R A Soo |
|---|---|
| Rok vydání: | 2012 |
| Předmět: |
Adult
Male Oncology medicine.medical_specialty Colorectal cancer medicine.medical_treatment colorectal cancer Early Therapy CT measurement Internal medicine Antineoplastic Combined Chemotherapy Protocols Secondary Prevention medicine Humans Radiology Nuclear Medicine and imaging In patient Neoplasm Metastasis Survival analysis Aged Retrospective Studies Aged 80 and over Chemotherapy tumor response Radiological and Ultrasound Technology business.industry therapy response Liver Neoplasms Retrospective cohort study General Medicine Middle Aged Prognosis medicine.disease Survival Analysis Treatment Outcome Median time Female Original Article Colorectal Neoplasms Tomography X-Ray Computed business Ct measurements |
| Zdroj: | Cancer Imaging |
| ISSN: | 1470-7330 |
| DOI: | 10.1102/1470-7330.2012.0021 |
| Popis: | Objectives: Patients with advanced stage colorectal carcinoma (CRC) display hepatic metastases on initial staging in up to 20% of cases. The effectiveness of chemotherapy is generally evaluated by computed tomography (CT) imaging using standardized criteria (RECIST). However, RECIST is not always optimal, and other criteria have been shown to correlate with pathologic response and overall survival. The aim of this study was to evaluate the prognostic value of different CT measurement for response assessment after initiation of chemotherapy in patients with synchronous colorectal cancer liver metastases. Methods: Fifty-five patients with CRC and synchronous hepatic metastases were evaluated retrospectively at 2 academic centers. Different size, volume, ratio and attenuation parameters were determined at baseline and after 3 cycles of chemotherapy. The prognostic value of baseline measurements and of the change between baseline and second measurements was analyzed using Kaplan–Meier estimates. Results: Median time to progression was 279 days, median overall survival was 704 days. In this selective patient population, neither a significant prognostic value of initial baseline CT parameters nor a prognostic value of the change between the first and the second CT measurements was found. Conclusion: Initial morphological response assessment using different CT measurements has no prognostic value concerning time to progression or overall survival in patients with synchronous colorectal liver metastases. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink